Jeffrey Eisele, the Chief Development Officer at Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.8 billion market cap biopharmaceutical company, recently sold a portion of his holdings in the ...
Find insight on oil prices, Tullow Oil, Shell and more in the latest Market Talks covering energy and utilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback